Press Releases - 2023-04-20

Date	Title	Company
20-Apr-2023	Durable Medical Equipment Rental Market in Japan is projected to register a CAGR of nearly 7.4% during 2023 to 2033 \| FMI Analyst	MARKITWIRED
20-Apr-2023	Disposable EEG Electrode Market in Japan is projected to register a CAGR of nearly 4.8% from 2023 to 2033 \| FMI	MARKITWIRED
20-Apr-2023	Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023	Businesswire
20-Apr-2023	Cytokine Release Syndrome Management Market to expand at a CAGR of 6.7% by 2033 \| FMI Project	MARKITWIRED
20-Apr-2023	Lifespin Announces Inaugural Membership in the Industrial Participant Program of the Wyss Diagnostics Accelerator at Harvard University	Businesswire
20-Apr-2023	GE HealthCare’s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance	Businesswire
20-Apr-2023	Lonza Increases Straight Bond by CHF 150 Million	Lonza Group AG
20-Apr-2023	Qosina Teams up with DuPont™ Liveo™ Healthcare Solutions to Market Its Liveo™ Biopharmaceutical-grade Tubing	Businesswire
20-Apr-2023	Azura Ophthalmics to Present New Data on AZR-MD-001 in Meibomian Gland Dysfunction at American Society of Cataract and Refractive Surgery and Association for Research in Vision and Ophthalmology Annual Meetings	Businesswire
20-Apr-2023	TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic	Businesswire
20-Apr-2023	Ora to Showcase New Technologies and Research Findings at ARVO 2023	Businesswire
20-Apr-2023	Horizon Therapeutics plc Announces UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the 2023 American Academy of Neurology (AAN) Annual Meeting	Businesswire
20-Apr-2023	MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer	Businesswire
20-Apr-2023	Visus Therapeutics Announces Positive Topline Clinical Data from Phase 3 Pivotal BRIO-I Trial of BRIMOCHOL PF™ for the Treatment of Presbyopia	Businesswire
20-Apr-2023	Precision BioSciences to Present Preclinical In Vivo Gene Editing Research for its ARCUS HBV Program at Upcoming Global Hepatitis Summit 2023	Businesswire
20-Apr-2023	Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan	Businesswire
20-Apr-2023	Areteia Therapeutics Announces Appointment of Elyse Stock, M.D. To Board of Directors	Businesswire
20-Apr-2023	Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System	Businesswire
20-Apr-2023	BeiGene Announces Positive Phase 3 Tislelizumab Trial in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma	Businesswire
20-Apr-2023	Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented Epithelium Stem Cell (RPESC) Technology for Treatment of Dry Age-Related Macular Degeneration in Panel Session at ARVO 2023	Businesswire